Acrivastine and pseudoephedrine and Tisagenlecleucel Intravenous
Determining the interaction of Acrivastine and pseudoephedrine and Tisagenlecleucel Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: acrivastine / pseudoephedrine
Brand name: Semprex-D
Synonyms: Acrivastine and Pseudoephedrine
Generic Name: tisagenlecleucel
Brand name: Kymriah
Synonyms: Tisagenlecleucel
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Acrivastine and pseudoephedrine-Titralac
- Acrivastine and pseudoephedrine-Tivicay
- Acrivastine and pseudoephedrine-Tivicay (Dolutegravir 10 mg)
- Acrivastine and pseudoephedrine-Tivicay (Dolutegravir 25 mg and 50 mg)
- Acrivastine and pseudoephedrine-Tivorbex
- Acrivastine and pseudoephedrine-Tizanidine
- Tisagenlecleucel Intravenous-Actamin
- Tisagenlecleucel Intravenous-Actamin Maximum Strength
- Tisagenlecleucel Intravenous-Actemra
- Tisagenlecleucel Intravenous-Actemra (Tocilizumab (Intravenous))
- Tisagenlecleucel Intravenous-Actemra (Tocilizumab Auto-Injectors)
- Tisagenlecleucel Intravenous-Actemra (Tocilizumab Prefilled Syringes)